[PDF][PDF] Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in …

…, LH Schwartz, JM Zijlstra, BA Siegel… - Journal of clinical …, 2007 - researchgate.net
Siegel, Radiology Corporation of America, Cardinal Health, Siemens Medical Solutions,
Spectrum Dynamics, Tyco Healthcare/Mallinckrodt Stock: Ali Guermazi, Synrac Inc; Barry A …

Recommendations on the use of 18F-FDG PET in oncology

…, B Djulbegovic, HP Soares, BA Siegel… - Journal of Nuclear …, 2008 - Soc Nuclear Med
The rationale was to develop recommendations on the use of 18 F-FDG PET in breast,
colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, …

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0

…, ML Brown, HD Royal, BA Siegel… - Journal of nuclear …, 2006 - Soc Nuclear Med
PET is a tomographic scintigraphic technique in which a computer-generated image of local
radioactive tracer distribution in tissues is produced through the detection of annihilation …

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

…, MA Rea, PE Foye, M Racke, AL Slone, BW Siegel… - Neuron, 1993 - cell.com
We report the cloning and characterization of a novel serotonin receptor, designated as 5-HT,,
which is coupled to the stimulation of adenylyl cyclase. 5-HT7 mRNA is expressed …

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials

…, S Larson, DA Mankoff, BA Siegel… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Despite the increasing use of 18F-FDG PET as a biomarker for predicting therapeutic response,
there are no widely accepted standardized protocols for using 18F-FDG PET as a tool …

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

…, JM Hoffman, B Johnson, HI Scher, BA Siegel… - Clinical Cancer …, 2005 - AACR
2-[ 18 F]Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique offers a …

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose …

…, DC Linehan, F Dehdashti, BA Siegel… - Annals of …, 2004 - journals.lww.com
Objective: To report the first 5-year overall survival results in patients with colorectal carcinoma
metastatic to the liver who have undergone hepatic resection after staging with [18 F] …

Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer

…, S Mutic, TR Miller, F Dehdashti, BA Siegel… - International Journal of …, 2004 - Elsevier
PURPOSE: Locoregional failure remains a significant problem for patients receiving definitive
radiation therapy alone or combined with chemotherapy for non–small-cell lung cancer (…

Lymph node staging by positron emission tomography in patients with carcinoma of the cervix

PW Grigsby, BA Siegel, F Dehdashti - Journal of Clinical Oncology, 2001 - ascopubs.org
PURPOSE: The aim of this study was to compare the results of computed tomography (CT)
and positron emission tomography (PET) with [ 18 F]-fluoro-2-deoxy-d-glucose (FDG) for …

Breast cancer: PET imaging of estrogen receptors.

MA Mintun, MJ Welch, BA Siegel, CJ Mathias… - Radiology, 1988 - pubs.rsna.org
Thirteen patients with primary breast masses were studied with positron emission tomography
(PET) and 16 alpha-[fluorine-18]-fluoroestradiol-17 beta. PET images demonstrated …